- Linee guida AIOM 2015 – Tumori del colon retto [Apri]
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E. Van Cutsem et al - Annals of Oncology 25 (Supplement 3): iii1–iii9, 2014 [Apri]
- eUpdate – Metastatic Colorectal Cancer Treatment Recommendations - Published: 20 September 2016. ESMO Guidelines Committee [Apri]
- ClinicalTrial.gov. A service of the U.S. National Institutes of Health [Apri]
Approfondimenti generali
Referenze bibliografiche specifiche
- Petrelli F, et al. Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016. [Apri]
- Chen K, et al. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon2 non-mutant) metastatic colorectal cancer: a nationwide cohort study. BMC Cancer 2016;16:327 [Apri]
- Jonker DJ, et al. Cetuximab for the Treatment of Colorectal Cancer. N Engl J Med 2007;357:2040-2048. [Apri]
©Accademia Nazionale di Medicina - Tutti i diritti riservati | Webmaster | Privacy policy
Realizzato da 